产品中心Cell Resources
联系我们CONTACT US
400-999-210024小时服务热线
![LN229 [LN-229; LNT-229]细胞专用培养基](/Public/upfile/pic/product/CM-0578-1.jpg)
![LN229 [LN-229; LNT-229]细胞专用培养基](/Public/upfile/pic/product/CM-0578-2.jpg)
产品概述
产品简介
LN229 [LN-229; LNT-229]细胞专用培养基由普诺赛技术团队精心优化，经过长期测试，本产品可保持LN229 [LN-229; LNT-229]细胞最佳的生长状态。本产品中已包含LN229 [LN-229; LNT-229]细胞生长所需的各种成分，无需添加任何成分，可直接用于LN229 [LN-229; LNT-229]细胞的体外培养。本产品仅供进一步科研使用，不得用于诊断、治疗、临床、家庭及其它用途。
产品说明
| 产品形态 | 液体 |
| 产品浓度 | 1× |
| 产品规格 | 125mL×4 |
| 培养基成分 | DMEM(PM150210)＋5% FBS(164210-50)＋1% P/S(PB180120) |
| 细菌检测 | 阴性 |
| 真菌检测 | 阴性 |
| 支原体检测 | 阴性 |
| 细胞生长实验 | 细胞生长良好，形态正常 |
| 内毒素含量(EU/mL) | ≤3 |
| 储存条件 | 2-8℃，避光储存 |
| 运输条件 | 冰袋冷藏运输 |
| 有效期 | 6个月 |
注意事项
参考文献
-
VSIG4 Silencing Inhibits Glioblastoma Growth by Regulating the JAK2/STAT3 Pathway (2023-06-02)
作者：Congying Zheng:1.Department of Neurosurgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou City, Guangdong Province, People's Republic of China. ; Chengliang Mao:1.Department of Neurosurgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou City, Guangdong Province, People's Republic of China. ; Kai Tang:1.Department of Neurosurgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou City, Guangdong Province, People's Republic of China. ; Hang Shu:1.Department of Neurosurgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou City, Guangdong Province, People's Republic of China. ;
期刊：VSIG4 Silencing Inhibits Glioblastoma Growth by Regulating the JAK2/STAT3 Pathway
影响因子 ：3.2
引用产品： U251 细胞 , LN229 [LN-229; LNT-229] 细胞 , U251细胞专用培养基 , LN229 [LN-229; LNT-229]细胞专用培养基
-
A novel necroptosis-related gene signature for predict prognosis of glioma based on single-cell and bulk RNA sequencing (2022-08-30)
作者：Kai Guo:1.Department of Neurosurgery, The Second Hospital of Hebei Medical University, Shijiazhuang, China. ; 2.Department of Neurosurgery, Affiliated Xing Tai People Hospital of Hebei Medical University, Xingtai, China. ; Xinxin Duan:1.Department of Oncology, Hebei General Hospital, Shijiazhuang, China. ; 2.Graduate School, North China University of Science and Technology, Tangshan, China. ; Jiahui Zhao:1.Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. ; Boyu Sun:1.Department of Neurosurgery, The Second Hospital of Hebei Medical University, Shijiazhuang, China. ; Xiaoming Liu:1.Department of Neurosurgery, The Second Hospital of Hebei Medical University, Shijiazhuang, China. ; Zongmao Zhao:1.Department of Neurosurgery, The Second Hospital of Hebei Medical University, Shijiazhuang, China. ;
期刊：A novel necroptosis-related gene signature for predict prognosis of glioma based on single-cell and bulk RNA sequencing
影响因子 ：6.1
引用产品： U-118 MG 细胞 , U138 细胞 , LN229 [LN-229; LNT-229] 细胞 , HS 683 细胞 , U-118 MG细胞专用培养基 , U138 细胞专用培养基 , LN229 [LN-229; LNT-229]细胞专用培养基 , HS 683细胞专用培养基
FAQs
Q：{{item.question}}
A：
产品资料
识别码示意图
